Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer Surgery

NCT ID: NCT02279771

Last Updated: 2022-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anastomotic leak after low rectal cancer surgery occurs between 3 and 24% of the cases and is a severe complication leading to sepsis, permanent colostomy, higher risk of local cancer recurrence and eventually death. In order to prevent this complication a protecting diverting stoma is usually fashioned with consequent morbidity due to the stoma and its closure and severe impact on patients' quality of life. This prospective, multi-center, parallel-arm, randomized controlled equivalence trial is aimed to demonstrate whether a transanal reinforcement of the suture line can prevent anastomotic leakage after low rectal cancer surgery thus avoiding the need for a covering ileostomy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

transanal anastomotic reinforcement

Low anterior resection with TME plus anastomotic transanal reinforcement without protective ileostomy/colostomy (transanal anastomotic reinforced arm:TAR-LAR)

Group Type ACTIVE_COMPARATOR

transanal anastomotic reinforcement

Intervention Type PROCEDURE

a circular anal dilator (CAD) of 34mm in diameter will be introduced into the anus to facilitate the transanal introduction of the 29-31 circular stapler. The stapler shaft will be introduced trying to avoid the stapler line and connected with the anvil of the prepared proximal colon and then fired.

Patients selected on the TAR-LAR arm will have the stapled suture reinforced by 6 supplemental full thickness stitches in vycril 3/0 placed transanally with the aid of a semicircular valve introduced into the CAD (Epo Flier, SapiMed SPA, Alessandria, Italy), at hours 2-4-6-8-10-12.

a circular anal dilator (CAD)

Intervention Type DEVICE

Epo Flier, SapiMed SPA, Alessandria, Italy

protective ileostomy group

Standard low anterior resection with TME plus protective ileostomy/colostomy (S-LAR)

Group Type ACTIVE_COMPARATOR

protective ileostomy group

Intervention Type PROCEDURE

S-LAR patients will had a standard lateral protective ileostomy in the right iliac region or a colostomy in the left region.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transanal anastomotic reinforcement

a circular anal dilator (CAD) of 34mm in diameter will be introduced into the anus to facilitate the transanal introduction of the 29-31 circular stapler. The stapler shaft will be introduced trying to avoid the stapler line and connected with the anvil of the prepared proximal colon and then fired.

Patients selected on the TAR-LAR arm will have the stapled suture reinforced by 6 supplemental full thickness stitches in vycril 3/0 placed transanally with the aid of a semicircular valve introduced into the CAD (Epo Flier, SapiMed SPA, Alessandria, Italy), at hours 2-4-6-8-10-12.

Intervention Type PROCEDURE

protective ileostomy group

S-LAR patients will had a standard lateral protective ileostomy in the right iliac region or a colostomy in the left region.

Intervention Type PROCEDURE

a circular anal dilator (CAD)

Epo Flier, SapiMed SPA, Alessandria, Italy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Resectable, histologically proven primary adenocarcinoma of the medium-low rectum without internal and/or external sphincter muscle involvement.

Distal margin of the tumor at least 6 cm form the anal verge

Staged as follows prior to neoadjuvant chemoradiation:

Stage T2 - T4 at MRI N0-2 at MRI M0/M1 at CT scan Patient classified T3-T4 must undergo neoadjuvant chemoradiation with at least 8 weeks delay of surgery

Exclusion Criteria

* Squamous cell carcinoma
* Adenocarcinoma Stage T1,
* T4 with one of the following:

with pelvic side wall involvement requiring sacrectomy requiring prostatectomy (partial or total)

* Unresectable primary rectal cancer or Inability to complete R0 resection.
* Rectal cancer under 6 cm from the anal verge requiring colo-anal anastomosis
* Recurrent rectal cancer
* Previous pelvic malignancy
* Inability to sign informed consent
* Pregnancy
Minimum Eligible Age

30 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Donato F Altomare

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Donato F Altomare

Associate professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arcangelo Picciariello, MD

Role: PRINCIPAL_INVESTIGATOR

Societa Italiana di Chirurgia ColoRettale

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bari, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Donato F Altomare, MD

Role: CONTACT

3397593066

Maria Di Lena, MD

Role: CONTACT

+390805592107

References

Explore related publications, articles, or registry entries linked to this study.

Cong ZJ, Hu LH, Bian ZQ, Ye GY, Yu MH, Gao YH, Li ZS, Yu ED, Zhong M. Systematic review of anastomotic leakage rate according to an international grading system following anterior resection for rectal cancer. PLoS One. 2013 Sep 25;8(9):e75519. doi: 10.1371/journal.pone.0075519. eCollection 2013.

Reference Type BACKGROUND
PMID: 24086552 (View on PubMed)

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.

Reference Type BACKGROUND
PMID: 23335087 (View on PubMed)

Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg. 1982 Oct;69(10):613-6. doi: 10.1002/bjs.1800691019.

Reference Type BACKGROUND
PMID: 6751457 (View on PubMed)

Karanjia ND, Corder AP, Bearn P, Heald RJ. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg. 1994 Aug;81(8):1224-6. doi: 10.1002/bjs.1800810850.

Reference Type BACKGROUND
PMID: 7953369 (View on PubMed)

Fazio VW, Zutshi M, Remzi FH, Parc Y, Ruppert R, Furst A, Celebrezze J Jr, Galanduik S, Orangio G, Hyman N, Bokey L, Tiret E, Kirchdorfer B, Medich D, Tietze M, Hull T, Hammel J. A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg. 2007 Sep;246(3):481-8; discussion 488-90. doi: 10.1097/SLA.0b013e3181485617.

Reference Type BACKGROUND
PMID: 17717452 (View on PubMed)

Matthiessen P, Hallbook O, Andersson M, Rutegard J, Sjodahl R. Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis. 2004 Nov;6(6):462-9. doi: 10.1111/j.1463-1318.2004.00657.x.

Reference Type BACKGROUND
PMID: 15521937 (View on PubMed)

Gong JP, Yang L, Huang XE, Sun BC, Zhou JN, Yu DS, Zhou X, Li DZ, Guan X, Wang DF. Outcomes based on risk assessment of anastomotic leakage after rectal cancer surgery. Asian Pac J Cancer Prev. 2014;15(2):707-12. doi: 10.7314/apjcp.2014.15.2.707.

Reference Type BACKGROUND
PMID: 24568483 (View on PubMed)

Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M. Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg. 1998 Mar;85(3):355-8. doi: 10.1046/j.1365-2168.1998.00615.x.

Reference Type BACKGROUND
PMID: 9529492 (View on PubMed)

Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011 May;253(5):890-9. doi: 10.1097/SLA.0b013e3182128929.

Reference Type BACKGROUND
PMID: 21394013 (View on PubMed)

Branagan G, Finnis D; Wessex Colorectal Cancer Audit Working Group. Prognosis after anastomotic leakage in colorectal surgery. Dis Colon Rectum. 2005 May;48(5):1021-6. doi: 10.1007/s10350-004-0869-4.

Reference Type BACKGROUND
PMID: 15789125 (View on PubMed)

Testini M, Gurrado A, Portincasa P, Scacco S, Marzullo A, Piccinni G, Lissidini G, Greco L, De Salvia MA, Bonfrate L, Debellis L, Sardaro N, Staffieri F, Carratu MR, Crovace A. Bovine pericardium patch wrapping intestinal anastomosis improves healing process and prevents leakage in a pig model. PLoS One. 2014 Jan 29;9(1):e86627. doi: 10.1371/journal.pone.0086627. eCollection 2014.

Reference Type BACKGROUND
PMID: 24489752 (View on PubMed)

Baek SJ, Kim J, Kwak J, Kim SH. Can trans-anal reinforcing sutures after double stapling in lower anterior resection reduce the need for a temporary diverting ostomy? World J Gastroenterol. 2013 Aug 28;19(32):5309-13. doi: 10.3748/wjg.v19.i32.5309.

Reference Type BACKGROUND
PMID: 23983434 (View on PubMed)

Senagore A, Lane FR, Lee E, Wexner S, Dujovny N, Sklow B, Rider P, Bonello J; Bioabsorbable Staple Line Reinforcement Study Group. Bioabsorbable staple line reinforcement in restorative proctectomy and anterior resection: a randomized study. Dis Colon Rectum. 2014 Mar;57(3):324-30. doi: 10.1097/DCR.0000000000000065.

Reference Type BACKGROUND
PMID: 24509454 (View on PubMed)

Gastinger I, Marusch F, Steinert R, Wolff S, Koeckerling F, Lippert H; Working Group 'Colon/Rectum Carcinoma'. Protective defunctioning stoma in low anterior resection for rectal carcinoma. Br J Surg. 2005 Sep;92(9):1137-42. doi: 10.1002/bjs.5045.

Reference Type BACKGROUND
PMID: 15997447 (View on PubMed)

Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007 Aug;246(2):207-14. doi: 10.1097/SLA.0b013e3180603024.

Reference Type BACKGROUND
PMID: 17667498 (View on PubMed)

Bafford AC, Irani JL. Management and complications of stomas. Surg Clin North Am. 2013 Feb;93(1):145-66. doi: 10.1016/j.suc.2012.09.015.

Reference Type BACKGROUND
PMID: 23177069 (View on PubMed)

Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases. Int J Colorectal Dis. 2009 Jun;24(6):711-23. doi: 10.1007/s00384-009-0660-z. Epub 2009 Feb 17.

Reference Type BACKGROUND
PMID: 19221766 (View on PubMed)

Perez Dominguez L, Garcia Martinez MT, Caceres Alvarado N, Toscano Novella A, Higuero Grosso AP, Casal Nunez JE. Morbidity and mortality of temporary diverting ileostomies in rectal cancer surgery. Cir Esp. 2014 Nov;92(9):604-8. doi: 10.1016/j.ciresp.2013.12.011. Epub 2014 Jun 23. English, Spanish.

Reference Type BACKGROUND
PMID: 24969349 (View on PubMed)

Altomare DF, Pannarale OC, Lupo L, Palasciano N, Memeo V, Rubino M. Protective colostomy closure: the hazards of a "minor" operation. Int J Colorectal Dis. 1990 May;5(2):73-8. doi: 10.1007/BF00298472.

Reference Type BACKGROUND
PMID: 2358740 (View on PubMed)

Chiu A, Chan HT, Brown CJ, Raval MJ, Phang PT. Failing to reverse a diverting stoma after lower anterior resection of rectal cancer. Am J Surg. 2014 May;207(5):708-11; discussion 711. doi: 10.1016/j.amjsurg.2013.12.016. Epub 2014 Mar 12.

Reference Type BACKGROUND
PMID: 24791631 (View on PubMed)

Altomare DF, Delrio P, Shelgyn Y, Rybakov E, Vincenti L, De Fazio M, Simone M, Graziano G, Picciariello A. Transanal reinforcement of low rectal anastomosis versus protective ileostomy after total mesorectal excision for rectal cancer. Preliminary results of a randomized clinical trial. Colorectal Dis. 2021 Jul;23(7):1814-1823. doi: 10.1111/codi.15685. Epub 2021 May 10.

Reference Type DERIVED
PMID: 33891798 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Siccr/2014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.